top of page
Event Info: Events


Tue, Jun 14
|Online Event, Webinar via Zoom
HIV Masterclass - Implications of NADIA on 2nd line ART
The NADIA trial supports use of DTG + 2 NRTIs as second-line ART, even if NRTIs are predicted to have no activity, but resistance is a concern. Only active members are eligible for CPD accredited certificates.
Registration is closed
See other eventsbottom of page